SCHEMBL1685267

SCHEMBL1685267

CC1(CO)COC(=O)N1Cl

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.31
PRKCD Q05655 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15698517 0.82 MAPT (0.31)
SCHEMBL1685186 0.82
SCHEMBL15698561 0.81 GABRP (0.30)
SCHEMBL15698520 0.81
SCHEMBL2185843 0.80
SCHEMBL3247093 0.79
SCHEMBL12375276 0.78
SCHEMBL2186345 0.78
SCHEMBL4562194 0.77
SCHEMBL15698522 0.77 GABRP (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2864541-B1 METHODS OF USING COMBINATIONS OF A LIPASE AND AN OXIDANT FOR PITCH CONTROL IN PAPER MAKING PROCESSES AND PRODUCTS THEREOF BUCKMAN LABORATORIES INT INC (US) 2017-06-14 EP disclosed
EP-2864541-A1 METHODS OF USING COMBINATIONS OF A LIPASE AND AN OXIDANT FOR PITCH CONTROL IN PAPER MAKING PROCESSES AND PRODUCTS THEREOF Buckman Laboratories International, Inc (US) 2015-04-29 EP disclosed
US-8657996-B2 Methods of using combinations of a lipase and an oxidant for pitch control in paper making processes and products thereof BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2014-02-25 US disclosed
WO-2013191803-A1 METHODS OF USING COMBINATIONS OF A LIPASE AND AN OXIDANT FOR PITCH CONTROL IN PAPER MAKING PROCESSES AND PRODUCTS THEREOF BUCKMAN LABORATORIES INTERNATIONAL,INC. (US) 2013-12-27 WO disclosed
US-20130340959-A1 Methods Of Using Combinations Of A Lipase And An Oxidant For Pitch Control In Paper Making Processes And Products Thereof BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 2013-12-26 US disclosed
US-7923036-B2 Halogen-containing sanitizing composition PPG INDUSTRIES OHIO, INC. (US) 2011-04-12 US disclosed
US-20100080857-A1 HALOGEN-CONTAINING SANITIZING COMPOSITION PPG INDUSTRIES OHIO, INC. (US) 2010-04-01 US disclosed
US-5106559-A Contained colored metal comopound PPG INDUSTRIES, INC. (US) 1992-04-21 US disclosed
US-5049385-A Disinfectant PPG INDUSTRIES, INC. (US) 1991-09-17 US disclosed
US-4659484-A CONTROLLING LEGIONELLA BACTERIA WITH 3-CHLORO-2-OXAZOLIDINONES PPG INDUSTRIES, INC. (US) 1987-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100080857-A1 HALOGEN-CONTAINING SANITIZING COMPOSITION NBAS, BRPF1, PRXL2A EPHX1 4206/4885PRKCD 1668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.